Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Pancreatic Cancer Treatment
Resectability category, chemotherapy sequencing, biliary drainage, and supportive care shape a multimodal plan — not a single package.
Treatment follows stage, tumor location, vessel relationships, and overall fitness. Surgery is central for appropriately selected resectable disease; chemotherapy is part of most pathways. Borderline tumors often receive neoadjuvant therapy before any attempt at resection. Supportive care — enzymes, nutrition, pain control, and glucose management — is not optional add-on care; it sustains the whole plan.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
- Labeled on this figure: Resectability · Systemic therapy · Support.
- Related figures on this page: Head tumors: Whipple, Body/tail: distal resection.
Figure labels (English)
- Resectability
- Systemic therapy
- Support
Related educational figures
Tap a figure to enlarge.
Head tumors: Whipple Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
Head tumors: Whipple
Body/tail: distal resection Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
Body/tail: distal resection
Who may be a candidate?
- Patients with staging that defines resectable, borderline, or locally advanced disease
- Candidates for neoadjuvant therapy before reconsideration of surgery
- People needing jaundice management, enzymes, nutrition, and pain control alongside oncology
Possible advantages
- Resectability framing prevents both hasty futile operations and premature nihilism
- Neoadjuvant sequences can test biology and improve R0 odds in borderline cases
- Supportive care protects energy, digestion, and quality of life during treatment
Limits & realistic expectations
- Locally advanced arterial encasement usually precludes upfront curative resection
- Metastatic disease prioritizes systemic therapy over classic curative surgery
- Not every jaundiced patient needs a routine preoperative stent
Step-by-step overview
- 1
Confirm resectability class
Pancreas-protocol imaging places disease as resectable, borderline, or locally advanced — plus metastatic status.
- 2
Multidisciplinary plan
Surgery, medical oncology, gastroenterology, and radiology agree on sequencing and drainage needs.
- 3
Treat systemic risk
Neoadjuvant or adjuvant chemotherapy (and selected radiotherapy) follows evidence and board review.
- 4
Support the patient
Enzymes, nutrition, pain control, and glucose management run in parallel with cancer therapy.
- 5
Reassess after therapy
Borderline cases are restaged; conversion to resection is considered only when R0 odds and fitness align.
Key points
Surgical candidacy in three frames
Resectable disease without distant spread opens a resection conversation. Borderline vessel contact often leads to neoadjuvant therapy first. Locally advanced major arterial involvement usually means primary surgery is not appropriate — systemic therapy and selected conversion strategies come first.
- Resectable → surgery discussed early
- Borderline → neoadjuvant then restage
- Locally advanced → primary resection usually unsuitable
Chemotherapy and radiotherapy
Systemic therapy before and/or after surgery is common. Selected cases add radiotherapy. In advanced disease, chemotherapy plus molecularly guided options focuses on control and quality of life.
Supportive care is core treatment
Enzyme replacement, nutrition support, pain control, and glucose management protect energy and dignity through the pathway — they are not optional extras.
Neoadjuvant approach in borderline disease
Limited relationships with the portal vein, superior mesenteric vein, or arteries often lead to systemic therapy first. After restaging, experienced centers may discuss resection — including selected vascular resection — when R0 odds are realistic.
- Key note inside
When biliary stents help
Not every jaundiced patient needs routine preoperative stenting. Cholangitis, markedly elevated bilirubin, delayed surgery, or neoadjuvant plans are typical reasons for ERCP drainage; timing is joint.
- Key note inside
Important
Educational information only — this page is for education and does not replace a visit with your physician. Treatment sequencing is individualized after resectability imaging, fitness assessment, and tumor-board discussion.
Frequently asked questions
Does ‘cannot operate’ as a first phrase settle everything?
No. Resectability and conversion potential are clarified after quality imaging and multidisciplinary review — not after a single casual comment.
When is neoadjuvant chemotherapy used?
Often in borderline vessel relationships, and increasingly in selected resectable pathways per center protocol, to shrink disease and test biology before major surgery.
Do I always need a bile-duct stent before surgery?
No. Stenting is considered for cholangitis, very high bilirubin, planned neoadjuvant delay, or other clinical needs — timing is shared by surgery and gastroenterology.
What supportive treatments matter most?
Pancreatic enzyme replacement, nutrition support, pain control, and blood-sugar management often matter as much as the ‘main’ drugs for day-to-day function.
Can I get a second opinion?
Yes. Bring complete imaging discs and pathology; high-volume pancreatic boards frequently refine resectability and sequencing.
More chapters in this hub
Pancreatic Cancer Symptoms
Jaundice, pain, and other warning signs that need timely review
Pancreatic Cancer Diagnosis
How clinicians confirm the problem and stage the next steps
Pancreatic Cancer Operations
How Whipple and distal resection are chosen
Whipple Procedure
Whipple: what the procedure aims to do and who it fits
Distal Pancreatectomy
Distal pancreatectomy: what the procedure aims to do and who it fits
After Pancreatic Surgery
Enzymes, blood sugar, and warning signs after resection
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.